COVID-19 vaccination and immune thrombocytopenia: Cause for vigilance, but not panic
- PMID: 36820404
- PMCID: PMC9930930
- DOI: 10.1016/j.rpth.2023.100039
COVID-19 vaccination and immune thrombocytopenia: Cause for vigilance, but not panic
Figures
Similar articles
-
Vigilance regarding immune thrombocytopenic purpura after COVID-19 vaccine.Ir J Med Sci. 2022 Apr;191(2):919-920. doi: 10.1007/s11845-021-02614-2. Epub 2021 Mar 31. Ir J Med Sci. 2022. PMID: 33788135 Free PMC article.
-
Severe Immune Thrombocytopenia after COVID-19 Vaccination: Two Case Reports and a Literature Review.Intern Med. 2022 May 15;61(10):1581-1585. doi: 10.2169/internalmedicine.9177-21. Epub 2022 Mar 19. Intern Med. 2022. PMID: 35314552 Free PMC article. Review.
-
Simultaneous Occurrence of Immune-Mediated Thrombocytopenia and Myocarditis After mRNA-1273 COVID-19 Vaccination: A Case Report.J Korean Med Sci. 2022 May 30;37(21):e169. doi: 10.3346/jkms.2022.37.e169. J Korean Med Sci. 2022. PMID: 35638196 Free PMC article.
-
Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia.Vaccine. 2021 Nov 26;39(48):7052-7057. doi: 10.1016/j.vaccine.2021.10.030. Epub 2021 Oct 30. Vaccine. 2021. PMID: 34756770 Free PMC article.
-
Vaccine-associated thrombocytopenia.Thromb Res. 2022 Dec;220:12-20. doi: 10.1016/j.thromres.2022.09.017. Epub 2022 Sep 26. Thromb Res. 2022. PMID: 36265409 Review.
Cited by
-
Robotic Splenectomy as a Salvage Therapy Post Failed Splenic Embolization in Chronic Immune Thrombocytopenic Purpura Due to the COVID-19 Vaccine.Cureus. 2025 Mar 31;17(3):e81536. doi: 10.7759/cureus.81536. eCollection 2025 Mar. Cureus. 2025. PMID: 40314051 Free PMC article.
-
Immune Thrombocytopenia After COVID-19 Vaccine Requiring Splenectomy: A Case Report and Review of the Literature.Cureus. 2024 Feb 10;16(2):e53955. doi: 10.7759/cureus.53955. eCollection 2024 Feb. Cureus. 2024. PMID: 38469016 Free PMC article.
-
Adverse Events Following COVID-19 Vaccination in Adolescents: Insights From Pharmacovigilance Study of VigiBase.J Korean Med Sci. 2024 Mar 4;39(8):e76. doi: 10.3346/jkms.2024.39.e76. J Korean Med Sci. 2024. PMID: 38442719 Free PMC article.
-
Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan Individuals.Vaccines (Basel). 2025 May 23;13(6):553. doi: 10.3390/vaccines13060553. Vaccines (Basel). 2025. PMID: 40573884 Free PMC article.
References
-
- Grimaldi-Bensouda L., Michel M., Aubrun E., Leighton P., Viallard J.F., Adoue D., et al. A case-control study to assess the risk of immune thrombocytopenia associated with vaccines. Blood. 2012;120:4938–4944. - PubMed
-
- Garbe E., Andersohn F., Bronder E., Salama A., Klimpel A., Thomae M., et al. Drug-induced immune thrombocytopaenia: results from the Berlin Case-Control Surveillance Study. Eur J Clin Pharmacol. 2012;68:821–832. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources